A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions

NCT00864734 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Glyburide and Metformin Hydrochloride Tablets 5 mg/500 mg
DRUG: CLUCOVANCE® 5 mg/500 mg Tablets, single dose

Sponsor

Actavis Inc.